Search results
3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition
InvestorPlace· 6 hours agoAs a dividend growth investor, I try to cut through the noise and find what matters most, which are...
Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
NewMediaWire via Yahoo Finance· 2 days agoThree of the world's leading key opinion leaders (KOL) in neuroscience and schizophrenia to review...
Davis Capital Management Has $330,000 Holdings in Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 5 hours agoDavis Capital Management boosted its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 29.9% during the 1st quarter, Holdings Channel reports. The institutional investor owned ...
Carolina Wealth Advisors LLC Trims Stake in Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 6 hours agoCarolina Wealth Advisors LLC lowered its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 19.4% during the 1st quarter, according to its most recent disclosure with the Securities ...
See the Medical World Through Neurodivergent Doctors' Eyes
Medscape· 11 hours agoWith different strengths and challenges around learning, engaging socially, or completing certain...
Somerset Trust Co Has $820,000 Stake in Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 5 hours agoSomerset Trust Co boosted its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 11.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities ...
Alzheimer's Risk Higher If Mom Had Memory Problems
MedPage Today· 3 days agoCognitively normal people whose mothers had a history of dementia or significant memory impairment were more likely to have a higher burden of brain...
New hospital in downtown Indianapolis expected to open in 2027
WTHR Indianapolis· 1 day agoThe new IU Health hospital will combine adult care services at Methodist and University hospitals....
Arvinas announces new R&D leadership appointments By Investing.com
Investing.com· 3 days agoToday, Arvinas, Inc. (NASDAQ:ARVN), a pharmaceutical company specializing in the development of new...
Johnson & Johnson (NYSE:JNJ) Shares Bought by Davis Capital Management
ETF DAILY NEWS· 7 hours agoDavis Capital Management boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange ...